Altogether, this unprecedented level of insight and dissection in the mechanisms of action of ERα in bone metabolism could be of interest to treat bone disorders and to minimize serious health risks related to such treatment (mainly venous thromboembolism and/or breast cancer). The gene discussed is ESR1; the disease is breast carcinoma.